Exercise for Brain Regeneration in Epilepsy
Regenerating the Adult Human Brain Through Exercise
1 other identifier
interventional
10
1 country
1
Brief Summary
Nearly 100 million Americans are affected by neurological disorders with an overall cost above $765 billion for the more prevalent conditions. Given this significant burden, effective treatments to prevent dementia and new disease modifying therapies are urgently needed. Regeneration of lost neurons with new ones (i.e., neurogenesis) is compromised at early stages of dementia and in part correlates with cognitive impairment in Alzheimer's disease. Boosting the neurogenesis delays the cognitive impairment in animal models of dementia and has been proven beneficial in improving the memory in rodent studies. Aerobic exercise is the most potent known stimulator of neurogenesis in animal models. A crucial next step is to translate endogenous regenerative strategies to people. The purpose of this study is to demonstrate the feasibility and investigate the effects of an exercise program on neurogenesis and cognitive improvement in epilepsy patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Aug 2022
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2021
CompletedFirst Posted
Study publicly available on registry
January 5, 2022
CompletedStudy Start
First participant enrolled
August 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedDecember 6, 2023
December 1, 2023
2 years
November 30, 2021
December 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence to exercise and assessments
Number of completed exercise and assessment sessions
Through study completion, an average of 6 months
Secondary Outcomes (5)
Neurogenesis
13 weeks after first exercise session
Rey Auditory Verbal Learning Test (RAVLT) - Trial V
Baseline and 12 weeks after first exercise session
Rey Auditory Verbal Learning Test (RAVLT) - Summary score
Baseline and 12 weeks after first exercise session
WAIS-IV - Matrix Reasoning
Baseline and 12 weeks after first exercise session
Rey Complex Figure Test (RCFT)
Baseline and 12 weeks after first exercise session
Study Arms (2)
High-impact Exercise
EXPERIMENTALLow-impact Exercise
ACTIVE COMPARATORInterventions
Participants will be submitted to a 12-week high-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (80% of maximum) is reached, followed by 10 minutes of cool down.
Participants will be submitted to a 12-week low-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (40% of maximum) is reached, followed by 10 minutes of cool down.
Eligibility Criteria
You may qualify if:
- Age of 18 years or older
- Medically resistant mesial temporal lobe epilepsy
- Candidacy for standard or selective temporal lobectomy
You may not qualify if:
- Age of older than 65 years
- Pregnancy
- Physical disabilities or medical conditions preventing from participation in exercise program
- Inability to receive exercise equipment at home
- Cognitive/developmental disabilities restricting the participation in exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Southern California Department of Neurosurgery
Los Angeles, California, 90033, United States
Related Publications (1)
Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol. 2017 Apr;81(4):479-484. doi: 10.1002/ana.24897. No abstract available.
PMID: 28198092BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan J Russin, MD
University of Southern California
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Clinical Neurological Surgery
Study Record Dates
First Submitted
November 30, 2021
First Posted
January 5, 2022
Study Start
August 20, 2022
Primary Completion
August 31, 2024
Study Completion
August 31, 2024
Last Updated
December 6, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share